- Home
- BBLG
BBLG
Bone Biologics Corp
as 07-26-2024 4:00pm EST
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 2.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -16.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.00 - $11.76 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Bone Biologics Corp News
BBLG Breaking Stock News: Dive into BBLG Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
15 days ago
OTC Markets Hosts Virtual Investor Presentation with Jeff Frelick, CEO and President of Bone Biologics, and Deina Walsh, CFO, with Brad Sorensen, Senior Analyst at Zacks SCR
GlobeNewswire
a month ago
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Medical Device Network
a month ago
First patients treated in Bone Biologics spinal fusion trial
Business Wire
a month ago
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
Zacks Small Cap Research
a month ago
BBLG Marks Important Milestone
GlobeNewswire
a month ago
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
GlobeNewswire
a month ago
Bone Biologics Executives to be Interviewed in a “CEO Chat” by Zacks Small-Cap Research Analyst on June 20th
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare BBLG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBLG Bone Biologics Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.